Axonics, Inc.
NASDAQ: AXNX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Raymond W. Cohen
- Employees
- 797
- Headquarters
- Irvine, United States
- IPO year
- 2018
- Market cap
- $3.6B
- Website
- https://www.axonics.com
Loading AXNX…
Loading profile data…Frequently asked questions about AXNX
What does Axonics, Inc. (AXNX) do?
Axonics, Inc. is a medical device firm that focuses on developing and bringing to market sacral neuromodulation (SNM) solutions. These advanced SNM systems are designed to address a range of medical conditions, such as overactive bladder (including urinary urge incontinence and frequent urges to urinate), alongside fecal incontinence and non-obs...
Where does AXNX trade?
Axonics, Inc. (AXNX) trades on the NASDAQ Global Select.
What sector is AXNX in?
Axonics, Inc. (AXNX) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Axonics, Inc.?
Raymond W. Cohen is the chief executive officer of Axonics, Inc. (AXNX).
Where is Axonics, Inc. headquartered?
Axonics, Inc. is headquartered in United States.
Does AXNX pay a dividend?
Axonics, Inc. (AXNX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AXNX go public?
Axonics, Inc. (AXNX) completed its initial public offering in 2018.